Shree Ganesh Remedies Ltd

Shree Ganesh Rem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shree Ganesh Remedies Ltd

₹ 741 -0.87%
13 Dec - close price
ganeshremedies.com BSE: 540737
About

Shree Ganesh Remedies is engaged in chemical
manufacturing, specialising in pharmaceutical
intermediates and speciality chemicals.[1]

Key Points

Evolution of Business[1]
The company is changing its focus from Intermediates for Off-patent and generic drugs towards patented molecules requiring strong technical know how. The revenue contribution from Intermediates has also shifted from 90% to <60%.

Website BSE
  • Market Cap ₹ 951 Cr.
  • Current Price ₹ 741
  • High / Low ₹ 950 / 558
  • Stock P/E 33.9
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE 27.8 %
  • ROE 26.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 35.1% CAGR over last 5 years
  • Debtor days have improved from 88.5 to 58.9 days.
  • Promoter holding has increased by 1.17% over last quarter.
  • Company's median sales growth is 28.2% of last 10 years

Cons

  • Stock is trading at 7.14 times its book value
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
16.97 21.13 20.56 17.64 21.26 21.99 29.61 26.72 33.42 28.16 37.33 24.78 32.33
12.52 15.36 15.91 13.39 15.93 16.62 20.97 20.16 24.19 19.76 20.39 16.65 21.02
Operating Profit 4.45 5.77 4.65 4.25 5.33 5.37 8.64 6.56 9.23 8.40 16.94 8.13 11.31
OPM % 26.22% 27.31% 22.62% 24.09% 25.07% 24.42% 29.18% 24.55% 27.62% 29.83% 45.38% 32.81% 34.98%
0.44 0.88 1.14 0.65 0.73 1.40 0.34 0.73 0.80 0.83 1.32 0.54 0.19
Interest 0.03 0.03 0.02 0.19 -0.14 0.03 0.08 0.01 0.01 0.32 0.15 0.32 0.43
Depreciation 0.95 0.99 0.58 0.82 0.90 0.97 1.03 1.02 1.41 1.86 1.86 2.02 2.42
Profit before tax 3.91 5.63 5.19 3.89 5.30 5.77 7.87 6.26 8.61 7.05 16.25 6.33 8.65
Tax % 22.76% 25.40% 26.01% 26.22% 25.66% 24.44% 14.99% 27.64% 23.81% 37.16% 22.46% 26.70% 25.78%
3.02 4.20 3.84 2.87 3.94 4.35 6.70 4.54 6.55 4.43 12.59 4.65 6.42
EPS in Rs 2.36 3.28 3.00 2.24 3.08 3.40 5.23 3.55 5.12 3.46 9.84 3.62 5.00
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
13 18 16 16 20 27 35 58 49 71 91 126 123
10 14 14 14 16 22 26 47 35 53 68 84 78
Operating Profit 2 5 2 2 4 5 9 11 14 18 23 42 45
OPM % 19% 25% 13% 12% 21% 19% 25% 19% 28% 25% 26% 33% 37%
1 1 0 0 0 2 1 4 2 4 1 3 3
Interest 0 0 0 0 0 0 0 0 0 0 0 1 1
Depreciation 1 1 1 1 1 1 1 2 3 3 4 6 8
Profit before tax 2 5 2 2 4 6 9 13 13 18 20 38 38
Tax % 33% 32% 33% 34% 33% 28% 28% 24% 25% 26% 25% 26%
1 3 1 1 3 5 6 10 10 13 15 28 28
EPS in Rs 9.25 20.06 7.94 6.75 16.50 3.66 4.88 7.52 7.62 10.47 11.86 21.97 21.92
Dividend Payout % 0% 0% 0% 0% 0% 19% 18% 14% 18% 4% 2% 2%
Compounded Sales Growth
10 Years: 21%
5 Years: 29%
3 Years: 37%
TTM: 10%
Compounded Profit Growth
10 Years: 24%
5 Years: 35%
3 Years: 42%
TTM: 27%
Stock Price CAGR
10 Years: %
5 Years: 65%
3 Years: 32%
1 Year: 11%
Return on Equity
10 Years: 22%
5 Years: 24%
3 Years: 24%
Last Year: 27%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 1 1 1 1 1 9 9 9 10 12 13 13 13
Reserves 7 11 12 13 15 20 25 33 40 50 75 109 120
2 0 0 0 0 2 1 2 0 0 33 36 34
2 2 2 2 5 5 7 8 10 15 18 12 11
Total Liabilities 12 15 15 16 21 36 41 52 61 77 138 171 178
4 4 4 4 4 6 14 16 19 27 58 81 97
CWIP 0 0 0 0 0 0 0 0 2 3 15 17 3
Investments 0 0 0 0 0 4 4 7 3 0 0 5 7
8 10 11 11 17 25 23 29 37 47 64 69 72
Total Assets 12 15 15 16 21 36 41 52 61 77 138 171 178

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 5 -1 -2 2 -1 -5 4 3 13 17 30
0 -1 1 1 0 -3 -0 -3 -1 -12 -51 -33
-1 -0 -0 -0 -0 8 -0 -0 -1 -1 39 10
Net Cash Flow 0 3 -1 -0 2 4 -5 1 2 0 5 7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 100 45 93 133 136 78 101 104 99 94 112 59
Inventory Days 186 126 132 130 103 102 125 56 206 132 138 156
Days Payable 47 23 43 32 90 43 75 39 101 92 118 51
Cash Conversion Cycle 239 149 183 232 149 137 151 120 205 134 133 164
Working Capital Days 187 96 160 202 172 156 149 115 159 133 132 110
ROCE % 25% 44% 16% 12% 26% 27% 27% 33% 28% 33% 22% 28%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
69.12% 69.12% 69.12% 68.27% 68.27% 69.34% 69.34% 69.33% 69.33% 69.33% 69.33% 70.49%
0.02% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01%
30.86% 30.86% 30.88% 31.73% 31.72% 30.67% 30.66% 30.67% 30.66% 30.67% 30.66% 29.50%
No. of Shareholders 5,7415,7455,4655,8436,4726,7476,4077,3307,5187,0497,1868,508

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls